Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Averna

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 5, 2016
Under-prescription of statins in patients with non-alcoholic fatty liver diseaseM Del Ben, F Baratta, L Polimeni, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1989
Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic controlG Davì, M Averna, I Catalano, et al.
Thrombosis Research|June 1, 1982
Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabeticsG Davì, G B Rini, M Averna, et al.
The Journal of Biological Chemistry|January 31, 1998
Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathwayR A Srivastava, N Srivastava, M Averna, et al.
Journal of Lipid Research|May 1, 1999
Known mutations of apoB account for only a small minority of hypobetalipoproteinemiaJ Wu, J Kim, Q Li, et al.
Haemostasis|January 1, 1982
Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patientsG Davì, G B Rini, M Averna, et al.
Thrombosis and Haemostasis|August 24, 1982
Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patientsA Strano, G Davì, M Averna, et al.
Metabolism: Clinical and Experimental|September 1, 1997
Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoproteinemic kindred without any ApoB truncationJ I Pulai, M Averna, R A Srivastava, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 5, 2008
Down regulation of CD11b and CD18 expression in children with hypercholesterolemia: a preliminary reportF Martino, E Martino, M Iacobini, et al.
Molecular and Cellular Biochemistry|March 8, 2000
Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoBR A Srivastava, L Toth, N Srivastava, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 5, 2016
Under-prescription of statins in patients with non-alcoholic fatty liver diseaseM Del Ben, F Baratta, L Polimeni, et al.
Diabetes Research (Edinburgh, Scotland)|January 1, 1989
Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic controlG Davì, M Averna, I Catalano, et al.
Thrombosis Research|June 1, 1982
Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabeticsG Davì, G B Rini, M Averna, et al.
The Journal of Biological Chemistry|January 31, 1998
Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathwayR A Srivastava, N Srivastava, M Averna, et al.
Journal of Lipid Research|May 1, 1999
Known mutations of apoB account for only a small minority of hypobetalipoproteinemiaJ Wu, J Kim, Q Li, et al.
Haemostasis|January 1, 1982
Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patientsG Davì, G B Rini, M Averna, et al.
Thrombosis and Haemostasis|August 24, 1982
Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patientsA Strano, G Davì, M Averna, et al.
Metabolism: Clinical and Experimental|September 1, 1997
Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoproteinemic kindred without any ApoB truncationJ I Pulai, M Averna, R A Srivastava, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 5, 2008
Down regulation of CD11b and CD18 expression in children with hypercholesterolemia: a preliminary reportF Martino, E Martino, M Iacobini, et al.
Molecular and Cellular Biochemistry|March 8, 2000
Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoBR A Srivastava, L Toth, N Srivastava, et al.
Pageof 6